• Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Consensus Rating of "Moderate Buy" from Brokerages

    来源: Buzz FX / 08 11月 2024 04:55:17   America/New_York


    Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat November 8, 2024 Share Link copied to clipboard. Celldex Therapeutics, Inc. ( NASDAQ:CLDX - Get Free Report ) has ear
    Read more...
分享